---
figid: PMC6335350__fnins-12-01017-g0002
figlink: /pmc/articles/PMC6335350/figure/F2/
number: Figure 2
caption: 'Therapeutic approaches in Alzheimer''s disease: GSK3 Inactivation therapy:
  Neuroprotective compounds such as curcumin modulates PI3K/Akt/GSK3β pathway, leading
  to inactivation of tau hyperphosphorylation. Rechaperoning therapy: Modulation of
  HSPGs-Aβ interaction by heparanase; PPIases (Peptidyl-prolylcis/trans isomerases
  (PPIases) catalyzes the tau and APP from cis to trans forms, perturbing the amylodogenesis
  of Aβ. Antioxidant and Deacetylation Therapy: Resveratrol activates AMPK pathway
  which is in turn activates SIRT1, preventing tau from hyperphosphorylation by deacetylation.
  Hormonal therapy: E2(17β-estradiol) modulates the APP processing by activation of
  estrogen receptor β; Non-steroidal anti-inflammatory drugs (NSAIDs)/γ-secretase
  modulators (GSMs) and peroxisome proliferator-activated receptor-gamma (PPARγ) agonists
  regulate β-secretase by triggering APP through activated immune response. Metal
  chelating agents (Cloquinol, Cu, Zn, and Fe) are used to prevent the Aβ aggregation
  and amyloid formation. Cell cycle therapy: Cdk5 inhibitor functions as a neuroprotectant
  by preventing the proteolysis of p35–p25 pathogenic form. Cholinesterase inhibitor
  drugs maintain the level of acetylcholine in neuronal cells by inhibiting the enzymes
  from breakdown of the acetylcholine. Immunotherapy: Active and passive immunization
  is achieved against AD by using Aβ-42 with an adjuvant and anti-Aβ-42 (Sc-Fv&mAB),
  respectively. mTOR inhibitors: Rapamycin/rapalogs inhibit mTOR activity which in
  turn inhibits AD progression by suppressing hyperphosphorylation of tau and by promoting
  autophagy.'
pmcid: PMC6335350
papertitle: 'Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer''s
  Development.'
reftext: Zeba Mueed, et al. Front Neurosci. 2018;12:1017.
pmc_ranked_result_index: '33881'
pathway_score: 0.7493425
filename: fnins-12-01017-g0002.jpg
figtitle: 'Therapeutic approaches in Alzheimer''s disease: GSK3 Inactivation therapy:
  Neuroprotective compounds such as curcumin modulates PI3K/Akt/GSK3B pathway, leading
  to inactivation of tau hyperphosphorylation'
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6335350__fnins-12-01017-g0002.html
  '@type': Dataset
  description: 'Therapeutic approaches in Alzheimer''s disease: GSK3 Inactivation
    therapy: Neuroprotective compounds such as curcumin modulates PI3K/Akt/GSK3β pathway,
    leading to inactivation of tau hyperphosphorylation. Rechaperoning therapy: Modulation
    of HSPGs-Aβ interaction by heparanase; PPIases (Peptidyl-prolylcis/trans isomerases
    (PPIases) catalyzes the tau and APP from cis to trans forms, perturbing the amylodogenesis
    of Aβ. Antioxidant and Deacetylation Therapy: Resveratrol activates AMPK pathway
    which is in turn activates SIRT1, preventing tau from hyperphosphorylation by
    deacetylation. Hormonal therapy: E2(17β-estradiol) modulates the APP processing
    by activation of estrogen receptor β; Non-steroidal anti-inflammatory drugs (NSAIDs)/γ-secretase
    modulators (GSMs) and peroxisome proliferator-activated receptor-gamma (PPARγ)
    agonists regulate β-secretase by triggering APP through activated immune response.
    Metal chelating agents (Cloquinol, Cu, Zn, and Fe) are used to prevent the Aβ
    aggregation and amyloid formation. Cell cycle therapy: Cdk5 inhibitor functions
    as a neuroprotectant by preventing the proteolysis of p35–p25 pathogenic form.
    Cholinesterase inhibitor drugs maintain the level of acetylcholine in neuronal
    cells by inhibiting the enzymes from breakdown of the acetylcholine. Immunotherapy:
    Active and passive immunization is achieved against AD by using Aβ-42 with an
    adjuvant and anti-Aβ-42 (Sc-Fv&mAB), respectively. mTOR inhibitors: Rapamycin/rapalogs
    inhibit mTOR activity which in turn inhibits AD progression by suppressing hyperphosphorylation
    of tau and by promoting autophagy.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ALPP
  - PRKAA2
  - CDK19
  - CDK8
  - CDK9
  - ESR1
  - GSK3A
  - AKT2
  - BCHE
  - PRKAG2
  - PRKAB2
  - GSK3B
  - PRKAB1
  - FGFR3
  - AKT3
  - AKT1
  - ACHE
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK10
  - CDK13
  - CDKL1
  - CDK20
  - CDKL4
  - CDK2
  - CDK12
  - CDK14
  - CDK15
  - CDKL5
  - CDK11A
  - NR5A1
  - IL6
  - HSP90B1
  - CDKL2
  - CDK1
  - CDK11B
  - CDK18
  - MAPT
  - PRKAG3
  - PRKAA1
  - PRKAG1
  - TRAP1
  - CDK17
  - HSP90AB1
  - CDK16
  - SIRT1
  - CDKL3
  - MTOR
  - 178-estradiol
  - Acetylcholine
  - Rapamycin
  - Curcumin
  - Resveratrol
  - Cu
  - Zn
  - Cloquinol
  - Alzheimer's
genes:
- word: (Alpp
  symbol: ALPP
  source: hgnc_symbol
  hgnc_symbol: ALPP
  entrez: '250'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: ERa/
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: (Cholinesterase)
  symbol: Cholinesterase
  source: bioentities_symbol
  hgnc_symbol: BCHE
  entrez: '590'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: (Cholinesterase)
  symbol: Cholinesterase
  source: bioentities_symbol
  hgnc_symbol: ACHE
  entrez: '43'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: ACHE
  symbol: ACHE
  source: hgnc_symbol
  hgnc_symbol: ACHE
  entrez: '43'
- word: Cholinesterase
  symbol: Cholinesterase
  source: bioentities_symbol
  hgnc_symbol: ACHE
  entrez: '43'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: HSF-1
  symbol: hSF-1
  source: hgnc_alias_symbol
  hgnc_symbol: NR5A1
  entrez: '2516'
- word: HSP70,IL-6,Akt
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: (HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: Cholinesterase
  symbol: Cholinesterase
  source: bioentities_symbol
  hgnc_symbol: BCHE
  entrez: '590'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: Tau
  symbol: tau
  source: hgnc_alias_symbol
  hgnc_symbol: MAPT
  entrez: '4137'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: (HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: tau
  symbol: tau
  source: hgnc_alias_symbol
  hgnc_symbol: MAPT
  entrez: '4137'
- word: (HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: SIRT1
  symbol: SIRT1
  source: hgnc_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: Cdks
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: 178-estradiol
  source: MESH
  identifier: C520025
- word: Acetylcholine
  source: MESH
  identifier: D000109
- word: Rapamycin
  source: MESH
  identifier: D020123
- word: Curcumin
  source: MESH
  identifier: D003474
- word: Resveratrol
  source: MESH
  identifier: C059514
- word: Cu
  source: MESH
  identifier: D003300
- word: Zn
  source: MESH
  identifier: D015032
- word: Cloquinol
  source: ''
  identifier: ''
diseases:
- word: Alzheimer's
  source: MESH
  identifier: D000544
---
